Jane K. Burke-Miller

Dr. Jane K. Burke-Miller

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
JCJudith A. Cook
Judith A. Cook
HLH. Stephen Leff
H. Stephen Leff
CBCrystal R. Blyler
Crystal R. Blyler
PGPaul B. Gold
Paul B. Gold
RGRichard W. Goldberg
Richard W. Goldberg
JBJane K. Burke-Miller
Jane K. Burke-Miller
Research from JAMA Psychiatry — Results of a Multisite Randomized Trial of Supported Employment Interventions for Individuals With Severe Mental Illness

11 July 2008 in AIDS
Verified
Journal Article
Closed access
JCJudith A Cook
Judith A Cook
JBJane K. Burke-Miller
Jane K. Burke-Miller
MCMardge H Cohen
Mardge H Cohen
RCRobert L Cook
Robert L Cook
DVDavid Vlahov
David Vlahov
DGDennis D Grey
Dennis D Grey
Background: Longitudinal associations between patterns of crack cocaine use and progression of HIV-1 disease are poorly understood, especially among women. This study explores relationships between crack use and HIV-1 disease outcomes in a multicenter cohort of infected women. Methods: Subjects were 1686 HIV-seropositive women enrolled at six US research centers in the Women's Interagency HIV Study. Approximately 80% were non-white and 29% used crack during the study period. Cox survival and random regression analysis examined biannual observations made April 1996 through September 2004. Outcome measures included death due to AIDS-related causes, CD4 cell count, HIV-1 RNA level, and newly acquired AIDS-defining illnesses. Results: Persistent crack users were over three times as likely as non-users to die from AIDS-related causes, controlling for use of HAART self-reported at 95% or higher adherence, problem drinking, age, race, income, education, illness duration, study site, and baseline virologic and immunologic indicators. Persistent crack users and intermittent users in active and abstinent phases showed greater CD4 cell loss and higher HIV-1 RNA levels controlling for the same covariates. Persistent and intermittent crack users were more likely than non-users to develop new AIDS-defining illnesses controlling for identical confounds. These results persisted when controlling for heroin use, tobacco smoking, depressive symptoms, hepatitis C virus coinfection, and injection drug use. Conclusion: Use of crack cocaine independently predicts AIDS-related mortality, immunologic and virologic markers of HIV-1 disease progression, and development of AIDS-defining illnesses among women.

1 October 2005 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
JCJudith A. Cook
Judith A. Cook
ALAnthony F. Lehman
Anthony F. Lehman
RDRobert Drake
Robert Drake
WMWilliam R. McFarlane
William R. McFarlane
PGPaul B. Gold
Paul B. Gold
DGDennis D. Grey
Dennis D. Grey

1 June 2007 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
JCJudith A. Cook
Judith A. Cook
DGDennis D. Grey
Dennis D. Grey
JBJane K. Burke-Miller
Jane K. Burke-Miller
MCMardge H. Cohen
Mardge H. Cohen
DVDavid Vlahov
David Vlahov
ALAlexandra M. Levine
Alexandra M. Levine

1 April 2012 in Schizophrenia Research
Verified
Journal Article
Closed access
JCJudith A. Cook
Judith A. Cook
PSPamela Steigman
Pamela Steigman
SPSue Pickett
Sue Pickett
SDSita Diehl
Sita Diehl
AFAnthony Fox
Anthony Fox
JBJane K. Burke-Miller
Jane K. Burke-Miller

11 January 2006 in Community Mental Health Journal
Verified
Journal Article
Closed access
PDF file
JBJane K. Burke-Miller
Jane K. Burke-Miller
JCJudith A. Cook
Judith A. Cook
DGDennis D. Grey
Dennis D. Grey
LRLisa A. Razzano
Lisa A. Razzano
CBCrystal R. Blyler
Crystal R. Blyler
MCMartha Ann Carey
Martha Ann Carey